TIL
Instil Bio Inc.
7.10$
-0.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
Instil Bio Inc. (TIL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -37 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -5.3 | -30 | -122 | -180 | -82 | -56 | -37 | |
| 0.0 | 0.3 | 2.8 | 6.0 | 4.8 | 3.6 | 0.5 | |
| 0.3 | 1.7 | 26 | 30 | 18 | 17 | 8.7 | |
| 0.8 | 6.4 | 28 | – | – | – | – | |
| 0.4 | 1.5 | 4.4 | -9.6 | -9.0 | -13 | -0.6 | |
| 0.8 | 51 | 58 | 85 | 21 | 10 | 10 | |
| -0.8 | -51 | -474 | 115 | 41 | 54 | 25 | |
| – | – | 393 | – | – | – | – | |
| – | – | 0.0 | 70 | 8.1 | 2.8 | 0.0 | |
| 15 | 313 | 393 | 72 | 8.1 | 1.8 | 7.3 | |
| 8.9 | 233 | -204 | 5.6 | -33 | -0.1 | -3.8 | |
| -6.1 | -80 | -180 | -265 | -103 | -66 | -37 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.